Stereotaxis and Abbott Combine Technologies in First Integrated Procedures to Treat Arrhythmia…
ST. LOUIS, July 18, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the first patients have been successfully treated…